MBBS SAQ · Endocrinology / General Medicine
Phaeochromocytoma — the alpha-before-beta rule and the catecholamine crisis
A final-prof / NEET-PG SAQ on a classic phaeochromocytoma presenting with the episodic headache-sweating-palpitation triad and an adrenal incidentaloma. Tests recognition of the triad and the high-risk CT, the biochemical-first principle (plasma free metanephrines before any biopsy), the non-negotiable alpha-before-beta preoperative blockade with phenoxybenzamine, and the immediate intra-operative crisis response with IV phentolamine/nitroprusside — and the danger of a beta-blocker given first.
On this page
Study tools
Exam tags
Write your answer
Saved on this device. No marking — you are the marker.
Question
A 42-year-old man presents to the emergency department with episodes of severe throbbing headache, profuse sweating, palpitations and anxiety lasting about 20 minutes each, occurring two to three times a week. During a spell his blood pressure is 210/120 mmHg with marked pallor; between attacks he is normotensive but describes dizziness on standing. An outpatient CT performed for unrelated pain showed a 4 cm right adrenal mass with an unenhanced attenuation of 42 Hounsfield units and slow washout. Outline the diagnosis, the diagnostic strategy, the preoperative preparation, and the management of an intra-operative hypertensive crisis.
Model answer
Show the model answerShowHide
Diagnosis: phaeochromocytoma until proven otherwise. The classic triad of episodic headache, sweating and palpitations with hypertension, the striking pallor during spells, and an orthostatic drop are highly suggestive. The adrenal mass with high unenhanced attenuation (~42 HU) and slow washout on CT is the radiological signature of a phaeochromocytoma. The diagnosis is biochemical first, anatomical second.[1]
Diagnostic strategy — biochemistry before biopsy.[1]
- First line: plasma free metanephrines (or 24-hour urine fractionated metanephrines and catecholamines). Metanephrine/normetanephrine are produced continuously inside the tumour, so they are far more sensitive than the parent catecholamines.
- Stop interfering drugs before testing — tricyclic antidepressants, phenoxybenzamine, decongestants, caffeine, MAOIs — to avoid false positives.
- If biochemistry is equivocal, use the clonidine suppression test (a phaeo fails to suppress).
- Localise with CT or MRI (already done here); for extra-adrenal, metastatic, hereditary or large tumours add functional imaging — MIBG scintigraphy or 18F-DOPA / 68Ga-DOTATATE PET.
- Offer genetic testing (SDHx, RET, VHL, NF1, MAX, TMEM127) — over 30 percent of patients carry a germline mutation.
- CRITICAL: never biopsy an unblocked adrenal mass with raised metanephrines — it precipitates a fatal catecholamine crisis.
Preoperative preparation — the cardinal rule: ALPHA before BETA.[1][2]
- Phenoxybenzamine (a non-competitive, irreversible alpha-blocker) 10 mg twice daily, titrate up every 2 to 3 days over 10 to 14 days to about 1 mg/kg/day, until seated blood pressure is around 130/80 with a mild orthostatic drop and nasal congestion appears (a clinical sign of adequate blockade).
- Volume expansion with a high-salt diet and IV saline — chronic vasoconstriction has left the patient volume-depleted.
- Only then add a beta-blocker (propranolol or bisoprolol) for reflex tachycardia — never first.
- Goals: normotension, no orthostatic syncope, moderate tachycardia controlled; then proceed to laparoscopic adrenalectomy.
- Why alpha first? A beta-blocker given alone leaves alpha-1-mediated vasoconstriction unopposed, producing a catastrophic hypertensive crisis.
Intra-operative hypertensive crisis.[2]
- On tumour handling, catecholamine surge causes severe hypertension (often >200 systolic).
- Give IV phentolamine (short-acting alpha-blocker) boluses/infusion, or sodium nitroprusside or nicardipine infusion.
- Treat arrhythmia with a short-acting beta-blocker (esmolol) only after alpha-blockade is established.
- After tumour vessels are clamped, anticipate hypotension (sudden loss of catecholamines on a fully blocked, vasodilated patient) — give IV fluids and vasopressors (noradrenaline/phenylephrine); watch for hypoglycaemia (loss of catecholamine-driven hyperglycaemia) — monitor glucose.
- Intensive care post-operatively for haemodynamic and glucose monitoring.
Common errors
- Biopsying the adrenal mass before biochemistry — a phaeochromocytoma can be triggered into a fatal crisis; never biopsy an unblocked phaeo.
- Giving a beta-blocker before an alpha-blocker — unopposed alpha vasoconstriction precipitates a hypertensive crisis; always alpha first.
- Relying on random catecholamines or VMA instead of metanephrines — lower sensitivity; episodic release is missed.
- Not stopping interfering drugs before biochemical testing — false positives.
- Inadequate preoperative blockade or volume expansion — intra-operative haemodynamic instability and post-resection hypotension.
- Forgetting post-operative hypoglycaemia and lifelong biochemical surveillance — recurrence, metastasis and new primaries in hereditary disease.
Examiner notes
- The exam wants a structured answer: recognise the triad and the high-attenuation adrenal mass, state the biochemistry-first principle with metanephrines and the no-biopsy rule, then the alpha-before-beta preparation with phenoxybenzamine for 10 to 14 days, and the intra-operative crisis response with IV phentolamine/nitroprusside.[1][2]
- Full marks require stating the mechanism of why a beta-blocker must not be given first (unopposed alpha vasoconstriction) and the post-resection pitfalls (hypotension and hypoglycaemia).
- A strong candidate mentions genetic testing for all patients, functional imaging for extra-adrenal/metastatic disease, and the Endocrine Society 2014 guideline.[1]
References2ShowHide
- [1]Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 2014.PMID 24893135
- [2]Nazari MA, Hasan R, Haigney M, et al. Catecholamine-induced hypertensive crises: current insights and management. Lancet Diabetes and Endocrinology, 2023.PMID 37944546